Managing patient requests for Your investigational medicines

Expanded Access Programs (EAPs) allow companies to provide their investigational medicines to patients outside of the clinical trial setting, to fulfil unmet clinical needs.

WEP has put together a free resource outlining what to do, step-by-step, when considering using the expanded access pathway to provide treatment access. Please complete the form to the right to download the resource.